AxoGen (AXGN) Tops Q2 EPS by 2c

AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.38 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• CCHH signs $50M data center services deal in Malaysia
• BMO Capital Reiterates Outperform Rating on HF Sinclair (DINO)